Sterling Investment Advisors (Pennsylvania)’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-11,000	Closed	-$83K	–	450
2019 Q3	$83K	Buy	11,000 +5,000	+83%	+$37.7K	0.04%	162
2019 Q2	$81K	Buy	+6,000	New	+$81K	0.04%	164